Literature DB >> 2157660

Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity. Studies using electron paramagnetic resonance.

H R Lamche1, P T Silberstein, A C Knabe, D D Thomas, H S Jacob, D E Hammerschmidt.   

Abstract

High concentrations of corticosteroids inhibit granulocyte responses and disrupt agonist receptor function. Dose-response and time-course considerations make it unlikely that these effects are mediated via the glucocorticoid receptor, a concept further supported by the ability of sex steroids to work similar effects. We postulated that steroids nonspecifically altered granulocyte membrane fluidity, which we measured directly by electron paramagnetic resonance. As predicted, methylprednisolone caused a dose-dependent increase in order parameter (decrease in fluidity) calculated on the basis of EPR spectra, using 5-doxylstearic acid (5-DS) as a probe of resting PMN membranes. This trend was highly significant (P less than 0.001; P at 0.5 mg/ml less than 0.01). Qualitatively similar results (but with different dose-response features) were obtained with conjugated estrogen. Granulocyte agonists (such as PMA) showed an opposite effect, which was not oxidatively mediated and which was steroid-inhibitable. 16-DS showed less prominent effects, suggesting that the membrane leaflets were more strongly affected than was the deep region of the membrane. Ibuprofen, which has similar effects to those of methylprednisolone on PMN aggregation and receptor function, caused a fluidizing rather than a stiffening of the membrane; this surprising result may indicate that there is a critical range of membrane fluidity for normal function, outside of which--in either direction--agonist receptor dysfunction occurs. We conclude that the immediate effects of very high doses of steroids are probably not mediated by corticoid receptors; instead, they may be due to changes in membrane fluidity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157660     DOI: 10.1007/BF00914030

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

1.  Interactions of immunoglobulins with liposomes: an ESR and diffusion study demonstrating protection by hydrocortisone.

Authors:  H Schieren; G Weissmann; M Seligman; P Coleman
Journal:  Biochem Biophys Res Commun       Date:  1978-06-29       Impact factor: 3.575

2.  Spin-label measurements in membranes. With appendix: a use of computers in EPR spectroscopy.

Authors:  B J Gaffney; C M McNamee
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

3.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

Review 4.  Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.

Authors:  H S Jacob; P R Craddock; D E Hammerschmidt; C F Moldow
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

5.  Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.

Authors: 
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

6.  Serum complement levels in canine endotoxin shock: relation to survival and to corticosteroid therapy.

Authors:  C H Shatney; R C Lillehei
Journal:  Adv Shock Res       Date:  1983

7.  Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.

Authors:  D E Hammerschmidt; J G White; P R Craddock; H S Jacob
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Synergy among agents inhibiting granulocyte aggregation.

Authors:  D E Hammerschmidt; P J Flynn; P A Coppo; K M Skubitz; H S Jacob
Journal:  Inflammation       Date:  1982-06       Impact factor: 4.092

9.  Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids.

Authors:  S L Hong; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

10.  Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulation.

Authors:  K M Skubitz; D E Hammerschmidt
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

View more
  6 in total

1.  Physicochemical properties and transport of steroids across Caco-2 cells.

Authors:  Fried Faassen; Jan Kelder; Johan Lenders; Rob Onderwater; Herman Vromans
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

2.  Influence of temperature on the proliferative response of rainbow trout gonadal fibroblasts to cortisol and RU 486.

Authors:  J A Van Oostrom; N C Bols
Journal:  Fish Physiol Biochem       Date:  1991-06       Impact factor: 2.794

3.  Oxygen metabolites induced by phorbol myristate acetate increase lateral diffusion of wheat germ agglutinin-labeled glycoconjugates in human polymorphonuclear leukocytes.

Authors:  B Johansson; K E Magnusson
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

Review 4.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Non-genomic inhibitory effect of glucocorticoids on activated peripheral blood basophils through suppression of lipid raft formation.

Authors:  S Yamagata; K Tomita; H Sano; Y Itoh; Y Fukai; N Okimoto; N Watatani; S Inbe; H Miyajima; K Tsukamoto; H Santoh; H Ichihashi; A Sano; R Sato; Y Tohda
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

6.  Eosinophils capture viruses, a capacity that is defective in asthma.

Authors:  Yanaika S Sabogal Piñeros; Suzanne M Bal; Annemiek Dijkhuis; Christof J Majoor; Barbara S Dierdorp; Tamara Dekker; Esmée P Hoefsmit; Peter I Bonta; Daisy Picavet; Nicole N van der Wel; Leo Koenderman; Peter J Sterk; Lara Ravanetti; René Lutter
Journal:  Allergy       Date:  2019-05-15       Impact factor: 13.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.